国家药品监督管理局药品审评中心数据显示,2026年3月10日,Janssen Research & Development, LLC的JNJ-87189401 注射液 (皮下注射)申请已获受理,受理号为JXSL2600075。
BEIJING, March 7 (Xinhua) -- Over one third of China's major development targets for the 2026-2030 period will focus on resolving the pressing difficulties and problems that concern the people most, a ...
BEIJING, March 7 (Xinhua) -- Over one third of China's major development targets for the 2026-2030 period will focus on resolving the pressing difficulties and problems that concern the people most, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果